Novocure (NVCR) Reports Q3 Loss of $2.09/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Novocure (NVCR) Reports Q3 Loss of $2.09/Share

JMP Securities Starts NovoCure Ltd. (NVCR) at Market Outperform

October 27, 2015 8:18 AM EDT

JMP Securities initiated coverage on NovoCure Ltd. (NASDAQ: NVCR) with a Market Outperform rating and a price target of $43.00.

For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.

Shares of NovoCure Ltd. closed at $20.58 yesterday.

... More

Wedbush Starts NovoCure Ltd. (NVCR) at Outperform

October 27, 2015 7:28 AM EDT

Wedbush initiates coverage on NovoCure Ltd. (NASDAQ: NVCR) with a Outperform rating and a price target of $30.00.

Analyst Tao Levy commented, " NovoCure is a rapidly emerging, commercial stage company whose flagship Tumor Treating Fields (TTFields) technology reverses tumor growth by disrupting cell... More